These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 34270810)

  • 1. Rejoinder for discussions on correct and logical causal inference for binary and time-to-event outcomes in randomized controlled trials.
    Liu Y; Wang B; Tian H; Hsu JC
    Biom J; 2022 Feb; 64(2):246-255. PubMed ID: 34270810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correct and logical causal inference for binary and time-to-event outcomes in randomized controlled trials.
    Liu Y; Wang B; Yang M; Hui J; Xu H; Kil S; Hsu JC
    Biom J; 2022 Feb; 64(2):198-224. PubMed ID: 35152457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discussion on "Correct and logical causal inference for binary and time-to-event outcomes in randomized controlled trials" by Yi Liu, Bushi Wang, Miao Yang, Jianan Hui, Heng Xu, Siyoen Kil, and Jason C. Hsu.
    Pennello G; Xu D
    Biom J; 2022 Feb; 64(2):225-234. PubMed ID: 33377537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subgroup mixable inference on treatment efficacy in mixture populations, with an application to time-to-event outcomes.
    Ding Y; Lin HM; Hsu JC
    Stat Med; 2016 May; 35(10):1580-94. PubMed ID: 26646305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correct and logical inference on efficacy in subgroups and their mixture for binary outcomes.
    Lin HM; Xu H; Ding Y; Hsu JC
    Biom J; 2019 Jan; 61(1):8-26. PubMed ID: 30353566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
    Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
    Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Popperian epidemiology and the logic of bi-conditional modus tollens arguments for refutational analysis of randomised controlled trials.
    Koch E; Otarola A; Romero T; Kirschbaum A; Ortuzar E
    Med Hypotheses; 2006; 67(4):980-8. PubMed ID: 16730919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discussion on 'Correct and logical causal inference for binary and time-to-event outcomes in randomized controlled trials'.
    Xi D; Bretz F
    Biom J; 2022 Feb; 64(2):243-245. PubMed ID: 34117793
    [No Abstract]   [Full Text] [Related]  

  • 11. Causal logistic models for non-compliance under randomized treatment with univariate binary response.
    Ten Have TR; Joffe M; Cary M
    Stat Med; 2003 Apr; 22(8):1255-83. PubMed ID: 12687654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A short, animated video to improve good COVID-19 hygiene practices: a structured summary of a study protocol for a randomized controlled trial.
    Vandormael A; Adam M; Greuel M; Bärnighausen T
    Trials; 2020 Jun; 21(1):469. PubMed ID: 32493460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mobile phone messaging for facilitating self-management of long-term illnesses.
    de Jongh T; Gurol-Urganci I; Vodopivec-Jamsek V; Car J; Atun R
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD007459. PubMed ID: 23235644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment and implication of prognostic imbalance in randomized controlled trials with a binary outcome--a simulation study.
    Chu R; Walter SD; Guyatt G; Devereaux PJ; Walsh M; Thorlund K; Thabane L
    PLoS One; 2012; 7(5):e36677. PubMed ID: 22629322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
    Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
    Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.